A metagenome-wide association study of gut microbiota in type 2 diabetes - PubMed (original) (raw)
. 2012 Oct 4;490(7418):55-60.
doi: 10.1038/nature11450. Epub 2012 Sep 26.
Yingrui Li, Zhiming Cai, Shenghui Li, Jianfeng Zhu, Fan Zhang, Suisha Liang, Wenwei Zhang, Yuanlin Guan, Dongqian Shen, Yangqing Peng, Dongya Zhang, Zhuye Jie, Wenxian Wu, Youwen Qin, Wenbin Xue, Junhua Li, Lingchuan Han, Donghui Lu, Peixian Wu, Yali Dai, Xiaojuan Sun, Zesong Li, Aifa Tang, Shilong Zhong, Xiaoping Li, Weineng Chen, Ran Xu, Mingbang Wang, Qiang Feng, Meihua Gong, Jing Yu, Yanyan Zhang, Ming Zhang, Torben Hansen, Gaston Sanchez, Jeroen Raes, Gwen Falony, Shujiro Okuda, Mathieu Almeida, Emmanuelle LeChatelier, Pierre Renault, Nicolas Pons, Jean-Michel Batto, Zhaoxi Zhang, Hua Chen, Ruifu Yang, Weimou Zheng, Songgang Li, Huanming Yang, Jian Wang, S Dusko Ehrlich, Rasmus Nielsen, Oluf Pedersen, Karsten Kristiansen, Jun Wang
Affiliations
- PMID: 23023125
- DOI: 10.1038/nature11450
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al. Nature. 2012.
Abstract
Assessment and characterization of gut microbiota has become a major research area in human disease, including type 2 diabetes, the most prevalent endocrine disease worldwide. To carry out analysis on gut microbial content in patients with type 2 diabetes, we developed a protocol for a metagenome-wide association study (MGWAS) and undertook a two-stage MGWAS based on deep shotgun sequencing of the gut microbial DNA from 345 Chinese individuals. We identified and validated approximately 60,000 type-2-diabetes-associated markers and established the concept of a metagenomic linkage group, enabling taxonomic species-level analyses. MGWAS analysis showed that patients with type 2 diabetes were characterized by a moderate degree of gut microbial dysbiosis, a decrease in the abundance of some universal butyrate-producing bacteria and an increase in various opportunistic pathogens, as well as an enrichment of other microbial functions conferring sulphate reduction and oxidative stress resistance. An analysis of 23 additional individuals demonstrated that these gut microbial markers might be useful for classifying type 2 diabetes.
Comment in
- Genomics: Resident risks.
Oh J, Segre JA. Oh J, et al. Nature. 2012 Oct 4;490(7418):44-6. doi: 10.1038/490044a. Nature. 2012. PMID: 23038462 Free PMC article. - Disease genomics: Associations go metagenome-wide.
Flintoft L. Flintoft L. Nat Rev Genet. 2012 Nov;13(11):756. doi: 10.1038/nrg3347. Epub 2012 Oct 9. Nat Rev Genet. 2012. PMID: 23044828 No abstract available.
Similar articles
- Further analysis reveals new gut microbiome markers of type 2 diabetes mellitus.
Wang X, Xu X, Xia Y. Wang X, et al. Antonie Van Leeuwenhoek. 2017 Mar;110(3):445-453. doi: 10.1007/s10482-016-0805-3. Epub 2016 Dec 10. Antonie Van Leeuwenhoek. 2017. PMID: 27943013 - Genomics: Resident risks.
Oh J, Segre JA. Oh J, et al. Nature. 2012 Oct 4;490(7418):44-6. doi: 10.1038/490044a. Nature. 2012. PMID: 23038462 Free PMC article. - Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data.
Vital M, Howe AC, Tiedje JM. Vital M, et al. mBio. 2014 Apr 22;5(2):e00889. doi: 10.1128/mBio.00889-14. mBio. 2014. PMID: 24757212 Free PMC article. - Microbiota and diabetes: an evolving relationship.
Tilg H, Moschen AR. Tilg H, et al. Gut. 2014 Sep;63(9):1513-21. doi: 10.1136/gutjnl-2014-306928. Epub 2014 May 15. Gut. 2014. PMID: 24833634 Review. - Application of metagenomics in the human gut microbiome.
Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS. Wang WL, et al. World J Gastroenterol. 2015 Jan 21;21(3):803-14. doi: 10.3748/wjg.v21.i3.803. World J Gastroenterol. 2015. PMID: 25624713 Free PMC article. Review.
Cited by
- The Gut Microbiota Impacts Gastrointestinal Cancers through Obesity, Diabetes, and Chronic Inflammation.
Rumyantsev KA, Polyakova VV, Sorokina IV, Feoktistova PS, Khatkov IE, Bodunova NA, Zhukova LG. Rumyantsev KA, et al. Life (Basel). 2024 Sep 24;14(10):1219. doi: 10.3390/life14101219. Life (Basel). 2024. PMID: 39459519 Free PMC article. Review. - Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction.
Lu JZ, Ye D, Ma BL. Lu JZ, et al. Front Pharmacol. 2021 May 7;12:668418. doi: 10.3389/fphar.2021.668418. eCollection 2021. Front Pharmacol. 2021. PMID: 34025427 Free PMC article. Review. - Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients.
Maifeld A, Bartolomaeus H, Löber U, Avery EG, Steckhan N, Markó L, Wilck N, Hamad I, Šušnjar U, Mähler A, Hohmann C, Chen CY, Cramer H, Dobos G, Lesker TR, Strowig T, Dechend R, Bzdok D, Kleinewietfeld M, Michalsen A, Müller DN, Forslund SK. Maifeld A, et al. Nat Commun. 2021 Mar 30;12(1):1970. doi: 10.1038/s41467-021-22097-0. Nat Commun. 2021. PMID: 33785752 Free PMC article. - Lipid and energy metabolism in Wilson disease.
Mazi TA, Shibata NM, Medici V. Mazi TA, et al. Liver Res. 2020 Mar;4(1):5-14. doi: 10.1016/j.livres.2020.02.002. Epub 2020 Feb 19. Liver Res. 2020. PMID: 32832193 Free PMC article. - The human microbiome in hematopoiesis and hematologic disorders.
Manzo VE, Bhatt AS. Manzo VE, et al. Blood. 2015 Jul 16;126(3):311-8. doi: 10.1182/blood-2015-04-574392. Epub 2015 May 26. Blood. 2015. PMID: 26012569 Free PMC article. Review.
References
- J Med Microbiol. 1995 Feb;42(2):78-82 - PubMed
- Nature. 2006 Dec 21;444(7122):1027-31 - PubMed
- Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):979-84 - PubMed
- Science. 2007 Jun 1;316(5829):1341-5 - PubMed
- N Engl J Med. 2008 Nov 20;359(21):2220-32 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical